Investors Can Lead the Class Action Against uniQure N.V. for Securities Fraud

A New Opportunity for Investors

In a significant development, investors of uniQure N.V. (NASDAQ: QURE) are now presented with the chance to lead a class action lawsuit regarding alleged securities fraud. Announced by the Rosen Law Firm, a premier firm recognized for advocating investors' rights, the lawsuit pertains to ordinary shares purchased between September 24, 2025, and October 31, 2025. This timeframe, known as the class period, is crucial for those who feel they may have been misled or suffered damages related to their investments in uniQure.

Background on the Allegations

The core of the lawsuit revolves around substantial claims that the company, during the aforementioned period, misrepresented crucial information regarding the approval and operational status of its product development, specifically related to a pivotal study for a drug candidate targeting Huntington's Disease. Key allegations suggest that the company failed to disclose the lack of full approval from the U.S. Food and Drug Administration (FDA) for its Pivotal Study. Investors were reportedly misled regarding the timeline for a Biologics License Application (BLA), as the study's presented results were not wholly supported by the requisite external historical data. When the truth was revealed, the stock's value reportedly suffered, leading to significant financial losses for shareholders.

What Investors Should Do

For investors who acquired shares within the specified period, it’s essential to act promptly. Those interested in potentially leading this class action can find more information through the Rosen Law Firm's dedicated webpage, where they can express their intention and obtain guidance. A key date to remember is April 13, 2026, by which time interested parties must file a motion to be considered for the lead plaintiff role in this class action. Participation can often result in compensation without any out-of-pocket costs, as plaintiffs in securities class actions typically operate under a contingency fee structure.

Importance of Choosing the Right Counsel

Choosing the right legal representation is paramount for investors looking to navigate the complexities of class action lawsuits. Rosen Law Firm has an established track record of success, having secured some of the largest class action settlements in history. Their team specializes in securities litigation, providing a wealth of experience specifically in handling cases that involve allegations of fraud and misrepresentation. Investors are encouraged to select counsel wisely, as many firms can only facilitate connections with qualified law firms without actually engaging in the litigation process themselves.

Conclusion

As the landscape of securities trading continues to evolve, it becomes increasingly important for investors to remain vigilant about the conditions surrounding their investments. If you have purchased uniQure N.V. shares during the specified period, consider exploring this opportunity. For additional information or inquiries about how to proceed, potential plaintiffs can reach out to the Rosen Law Firm directly. This not only represents a chance to seek justice but also highlights the broader commitment to transparency and ethical practices within the financial markets. Investors can monitor future updates and details about the case through Rosen Law Firm's official channels on social media platforms like LinkedIn, Twitter, and Facebook.